Lisa McElroy
Duke University, NC·Medicine & Clinical Research·Early-career
Organ transplantation is the best treatment for end-stage organ disease, improving both survival and quality of life. Yet Black and Hispanic patients have nearly three times the rate of end-stage organ disease of white patients but make up only 20% of transplant recipients.
- Fields
Medicine & Clinical Research
Public Health & Epidemiology
- Topics
organ transplantation
transplant access
end-stage organ disease
- Grants
- 1 known grant, through Jun 2027
What they work on
- Quantify how many patients are eliminated during the screening, evaluation and committee decision phases of transplant selection using electronic health record data.
- Characterize process weaknesses in each phase of transplant selection, including how center-level processes and individual clinician decisions impede access to transplant.
- Design and pilot a toolkit that transplant centers can use to standardize clinical practice and reduce obstacles at each step of the transplant selection process.
More about the research
How transplant centers decide who gets on the path to a transplant is not standardized, and national transplant data do not track this selection process, so hidden obstacles may block access.
Why it matters
Black and Hispanic patients with end-stage organ disease receive transplants far less often than their disease burden would predict. Identifying where patients are lost during transplant selection, and giving centers a toolkit to standardize the process, could help more patients reach transplant and reduce disparities in access.
Known grants
From NIH and NSF research grants. Labs often have other funding we can't see.
Closest labs
Katie Ross-Driscoll
Indiana University-Purdue University-Indianapolis, IN·Public Health & Epidemiology·Early-career
Identify patient, social and geographic factors linked to referral for liver transplant among patients with end-stage liver disease, using data from two transplant centers serving 108 counties across Georgia, Alabama, Tennessee and South Carolina.
Catherine Butler
University of Washington, WA·Medicine & Clinical Research·Early-career
Identify the concepts that matter in the kidney transplant evaluation experience, using a literature review, existing interview transcripts, and focus groups with referred patients, family members and clinicians.
Vishnu Potluri
University of Pennsylvania, PA·Medicine & Clinical Research·Early-career
Determine whether immunosuppression modifies the risk of post-transplant lymphoproliferative disorder in kidney recipients without prior Epstein-Barr virus infection who receive organs from infected donors, using validated data from an eight-center consortium.
The school
Duke University: 61 labs on PI Pages, $1.6B a year on research, 417 research doctorates a year.
Reach out
A start for your email. Fill in the brackets.